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Groupe d’e´tude des prote´ines membranaires (GE´PROM), De´partement de physique, Universite´ de Montre´al, Montre´al, Quebec, CanadaABSTRACT The Naþ/glucose cotransporter (SGLT1) is a membrane protein that couples the transport of two Naþ ions and
one glucose molecule using the so-called alternating access mechanism. According to this principle, each cotransporter mole-
cule can adopt either of two main conformations: one with the binding sites accessible to the extracellular solution and one with
the binding sites facing the intracellular solution. The turnover rate (TOR) is the number of complete cycles that each protein
performs per second. Determination of the TOR has important consequences for investigation of the cotransport mechanism,
as none of the rate constants involved in mediating transport in a given direction (conformational changes and binding and
unbinding reactions) can be slower than the TOR measured under the same conditions. In addition, the TOR can be used to
estimate the number of cotransporter molecules involved in generating a given ensemble activity. In this study, we obtain an
independent estimation of the TOR for human SGLT1 expressed in Xenopus laevis oocytes applying the ion-trap technique.
This approach detects the quantity of ions released in or taken up from the restricted space existing between the oocyte plasma
membrane and the tip of a large ion-selective electrode. Taking advantage of the fact that hSGLT1 in the absence of Naþ can
cotransport glucose with protons, we used a pH electrode to determine a TOR of 8.00 5 1.3 s1 in the presence of 35 mM
a-methyl-glucose at 150 mV (pH 5.5). For the same group of oocytes, a TOR of 13.3 5 2.4 s1 was estimated under
near-Vmax conditions, i.e., in the presence of 90 mM Na
þ and 5 mM a-methyl-glucose. Under these circumstances, the average
cotransport current was 1.085 0.61 mA (n ¼ 14), and this activity was generated by an average of 3.65 0.7  1011 cotrans-
porter molecules/oocyte.INTRODUCTIONCotransporters constitute a class of membrane proteins that
couple the transmembrane transport of several solutes. For
example, cotransporters can generate secondary active
transport by linking the (thermodynamically) downhill
movement of an ion to the uphill movement of a cotrans-
ported solute. The archetype of these proteins is the Naþ/
glucose cotransporter (SGLT1), which was first postulated
in 1965 (1) and uses the electrochemical gradient of Naþ
to drive the absorption of glucose into epithelial cells of
the small intestine and the renal proximal tubule. SGLT1
cDNAwas cloned in 1987 (2) which allowed its expression
in Xenopus laevis oocytes and its precise characterization
using two-electrode voltage-clamp electrophysiology and
voltage-clamp fluorometry (3–7). Unlike ion channels,
which fluctuate between states of different conductance,
cotransporters must engage in a cycle of conformational
changes, going through occluded states to translocate Naþ
and substrate across the lipid bilayer by exposing their
binding sites to one side of the membrane at a time. First
introduced by Jardetzky (8), the existence of such an alter-
nating access mechanism during cotransport is now sup-
ported by evidence drawn from structural studies (9,10)
including the recent crystallization of vSGLT (11), a bacte-
rial homolog of human SGLT1. The rate at which this cycle
of conformational changes occurs is called the turnover rateSubmitted July 23, 2010, and accepted for publication November 8, 2010.
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0006-3495/11/01/0052/8 $2.00(TOR) and is expressed as the average number of complete
cycles/s performed by a single cotransporter molecule. If
a cell expresses N electrogenic cotransporter molecules,
the cotransport current (ICotr) is given by
ICotr ¼ N  TOR  s  e; (1)
where s is the net number of elementary charges (e) trans-
ported during a complete transport cycle (s¼ 2 for SGLT1).
Over the last decades, different estimates have been made
for the SGLT1 TOR, but they do not agree on a consensus
value. The first estimate of TOR was made by Peerce
et al. (12) using binding experiments (3H phlorizin and fluo-
rescein isothiocyanate) and glucose uptake data on brush-
border membranes prepared from rabbit small intestine.
They suggested that the TOR of the Naþ/glucose cotrans-
porter was in the range 3–6 s1. In the first extended kinetic
study of rabbit SGLT1 expressed in oocytes (13), a six-state
model was described with a series of rate constants that
could reproduce the basic steady-state and pre-steady-state
electrophysiological observations. At negative membrane
potentials, the intracellular Naþ dissociation was suggested
to be the rate-limiting step at 10 s1, which implies that
TOR cannot be faster than 10 s1. It is also possible to
deduce the TOR of a cotransporter from measurement of
the phlorizin-sensitive charge displacement in the absence
of substrate (14). Given a few assumptions (see Discussion),
the ratio of ICotr to the maximal charge displaced (Qmax) is
an estimation of TOR and yields a value of 57 s1 (14)doi: 10.1016/j.bpj.2010.11.012
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a study from the same laboratory presented a revised estima-
tion of Qmax with prolonged voltage pulses, which led to
a TOR of 28 s1 (4). This last estimation of TOR would
suggest that a typical ICotr of 1 mA/oocyte would imply
the presence of 1.1  1011 carriers/oocyte. This is much
larger than the estimated density of particles associated
with SGLT1 protein using freeze-fracture electron micros-
copy (15).
In an effort to better delimit the TOR of SGLT1 and to
contrast it with the rate-limiting steps of different kinetic
models, we sought to use a method that is independent of
both the ICotr=Qmax ratio and of the detection of particles
putatively representing the presence of SGLT1 in the plasma
membrane. The ion-trap technique (ITT), an experimental
approach recently presented by our laboratory (16), offers
the possibility of shedding new light on the problem of
correctly estimating the value of TOR for hSGLT1.MATERIALS AND METHODS
Oocyte preparation and injection
Oocytes were surgically removed from Xenopus laevis frogs and were indi-
vidually separated before defolliculation, as described previously (17). One
to two days after the procedure, healthy oocytes were injected with 4.6 ng of
mRNA coding for human myc-hSGLT1 at a concentration of 0.1 mg/ml in
water. This N-terminus myc-tagged version of human SGLT1 was previ-
ously shown to be functionally indistinguishable from the untagged form
(17). Oocytes were kept in Barth’s solution (in mM, 90 NaCl, 3 KCl,
0.82 MgSO4, 0.41 CaCl2, 0.33 Ca(NO3)2, and 5 Hepes, pH 7.6) supple-
mented with 5% horse serum, 2.5 mM Naþ pyruvate, 100 units/ml peni-
cillin, and 0.1 mg/ml streptomycin for 4–5 days before performing
electrophysiological experiments.FIGURE 1 Experimental arrangement and pulse protocol used for the
ITT. (A) An oocyte is placed in a bath, observed with a low-power micro-
scope, and impaled with voltage and current electrodes to perform voltage-
clamp measurements. An ISE with a large tip diameter (50–100 mm) isSolutions
When needed, 5 mM a-methyl-D-glucose (aMG, a nonmetabolized
glucose analog) was added to the normal saline solution used for electro-
physiology (in mM, 90 NaCl, 3 KCl, 0.82 MgCl2, 0.74 CaCl2, and 10
HEPES, pH 7.5 with Tris). The pH 5.5 Naþ-free solution used for measure-
ments of Hþ/aMG cotransport was identical to the normal saline solution
with the exception that it was weakly buffered with 1.5 mM MES and
90 mM NaCl was replaced with 65 mM N-methyl-D-glucamine and
50 mM D-mannitol. To inhibit the cotransporter, 0.2 mM phlorizin (Pz)
was added. Given the low affinity of SGLT1 for aMG at acidic pH (18),
where the Km is 4 mM at 150 mV, measurement of Hþ/glucose cotrans-
port activity was done by adding 5 or 35 mM aMG to the acidic solution.
When 35 mM aMG was used, an equivalent amount of D-mannitol was
removed. Unless otherwise mentioned, all chemicals were obtained from
Sigma-Aldrich (St. Louis, MO).
gently pushed against the plasma membrane to create a confined space
called a trap between the plasma membrane infolding and the Hþ-selective
resin of the ISE. A reference electrode is placed in the bath near the ISE
tip to monitor local potential changes and correct the ISE signal (VH)
accordingly. (B) Voltage (Vm) pulse protocol and expected ISE signals.
Straight lines are fitted to the ISE signal at 150 mV and at þ50 mV to
obtain the two parameters used in the ITT: the slope and the step. The slope
is simply the rate at which VH changes at 150 mV. The step is the sudden
change in VH observed at the time that Vm is changed from þ50
to 150 mV.Electrophysiology and the ion-trap technique
Two-microelectrode voltage-clamp measurements and current filtering
(1 kHz) were performed using an OC-725C oocyte clamp (Warner Instru-
ment, Hamden, CT). Data recording was achieved using a Digidata
1322A acquisition system and pClamp 8.2 software (Axon Instruments,
Union City, CA). Voltage and current microelectrodes were filled with
1 M KCl and showed a resistance of 1–3 MU. The bath current electrodewas an Ag-AgCl pellet and the reference voltage electrode was a 1 M
KCl agar bridge.
The ion trap technique (ITT) has been described in detail in a recent
publication from this laboratory (16). Briefly, the technique consists in
measuring ionic concentrations at the surface of a voltage-clamped oocyte
using a large (tip diameter 50–100 mm) ion-selective electrode (ISE). To
improve the accuracy of the measurement when significant currents are
circulating in the bath, the signal of the ISE was corrected for any changes
in bath potential by using an additional reference microelectrode (filled
with 1 M KCl) positioned within 100 mm of the ISE (Fig. 1 A). When the
large-tip ISE is gently pushed against the oocyte plasma membrane,
it creates a small volume of extracellular solution called the trap (height
~5 mm) (16), which roughly corresponds to the thickness of the observed
plasma-membrane invaginations. ITT can be used to measure the steady-
state transport of an ion across the membrane lining the trap. For example,Biophysical Journal 100(1) 52–59
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the trap concentration of this ion within 20–30 s. ITT can also be used to
detect the initial rate of change in the trap ionic concentration when the
transmembrane transport of a given ion is suddenly changed. This can be
done by applying a fast voltage pulse to the oocyte while using the excellent
time resolution of the ISE (~20 ms). The initial binding of an ion to a newly
exposed binding site of a transporter will result in an abrupt change in local
ionic concentration that we call the step. In the following hundreds of milli-
seconds, the steady-state transmembrane ionic flux is reached, producing
a constant change in the voltage of the ISE that we call the slope (Fig. 1 B).
As explained below in greater detail, we chose to use pH-sensitive elec-
trodes instead of Naþ-sensitive electrodes to improve the accuracy in the
determination of the TOR. Electrophysiological and ITT measurements
were performed using five sequential repetitions of a voltage pulse protocol
with a holding potential of 50 mVand a 300-ms voltage step at þ50 mV
followed by a 500 ms hyperpolarization at 150 mV (Fig. 1 B). To obtain
an accurate value of the Hþ-selective electrode voltage (VH), the drift in VH
was corrected by subtracting the slope measured at 50 mV before
changing the membrane potential using a time window of 700 ms. After
this drift correction, a straight line was fitted to the VH measured in the
last 200 ms spent at þ50 mV and in the last 400 ms spent at 150 mV.
The instantaneous step in VH upon the sudden voltage changewas evaluated
by measuring the difference between the two straight lines at the timewhere
the voltage was stepped from þ50 to 150 mV (see Fig. 1 B). All signals
were sampled at a frequency of 1 point/0.15 ms, and the noise level on the
VH signal was further reduced by averaging 10 consecutive points (the final
signal displaying 1 data point/1.5 ms). The final VH signal was low-pass-
filtered using a cut-off frequency of 200 Hz.FIGURE 2 Charge displacement in hSGLT1. (A) Integration of the tran-
sient currents associated with hSGLT1 in the absence of glucose yields
a Q-V curve that can be fitted with a Boltzmann equation (see Eq. 2). In
this example, the Q-V curve shown is an average from 14 oocytes. It was
obtained in 0 mMNaþ and 0 mM aMG buffer (pH 5.5) and the fitted Boltz-
mann equation is characterized by a V1/2 of 94 mV, a z value of 0.45, and
a Qmax of 24 nC. (B) A simplified four-state kinetic model used to account
for pre-steady-state and cotransport currents. As previously proposed
(13,18,19), the cotransporter binding sites can be exposed to the intracel-
lular (C1) or to the extracellular side of the membrane (C2), where it can
bind two cations (here, two protons) to reach state C3. After binding a sugar
molecule, state C4 is reached and all the subsequent steps are combined into
a single step representing the reorientation of the binding sites toward the
intracellular side where sugar and ions are released. The reorientation of
the free binding sites and the cation binding step are assumed to be electro-
genic. In the external absence of sugar, but with cations present, a very
negative membrane potential would drive the cotransporter into state C3,
whereas a very positive potential would drive it into state C1.Estimating the cotransporter TOR using ITT
It is well established that the transport stoichiometry of SGLT1 is 2 Naþ
ions/glucose molecule (6,19,20) (i.e., s ¼ 2 in Eq. 1), but in the absence
of external Naþ, it also functions as a Hþ/glucose cotransporter (18,21).
The transport stoichiometry appears to be conserved (2 Hþ for 1 glucose
molecule), as suggested by the sigmoidal activation curve as a function
of external proton concentration. SGLT1 was studied in the absence of
Naþ using a weakly buffered acidic external solution (pH 5.5). In the
absence of substrate, oocytes expressing SGLT1 displayed Pz-sensitive
transient currents of large amplitude (22) that could be integrated to
yield a displaced charge Q for a given voltage pulse V. An example of











where Qmax ¼ (Q–  Qþ). Q– and Qþ represent the charge transferred
when the oocyte membrane potential moves from the resting potential to
a very negative or a very positive potential, respectively. Once fitted, the
data of Fig. 2 A are characterized by a V1/2 of 94 mV, a z of 0.45, and
a Qmax of 24 nC (n¼ 14). As a negative membrane potential (Vm) is known
to facilitate extracellular Naþ or Hþ binding, the cotransporter is assumed
to carry a displaceable negative charge that will move with the cation
binding site. This is depicted in the kinetic model shown in Fig. 2 B, which
is generally used to describe the activity of SGLT1 and other related
cotransporters (13,19,23,24). When Vm is positive, the cotransporter expe-
riences a conformational change that brings it into the C1 configuration
(inward-facing configuration). When Vm is changed to a negative value,
the cotransporter moves into configuration C2, where it can bind external
protons and reach the C3 configuration (the outward-facing cation-bound
configuration). The Q-V curve reflects these conformational changes and
shows that, at þ50 mV, the mobile charge has almost reached a limiting
value, indicating that most of the cotransporters are in the C1 configuration.
When Vm goes fromþ50 to150 mV in the absence of glucose, a fraction,
f, of the cotransporters moves into the C3 configuration. As seen fromBiophysical Journal 100(1) 52–59Fig. 2 A, such a voltage pulse would result in the displacement of 65% of
the mobile charges (i.e., from 10% outward-facing at þ50 mV to 75%
outward-facing at 150 mV).
In this ITT experiment, we are measuring the local proton concentration
at the external surface of an oocyte in the trap. As Vm is switched
from þ50 mV to 150 mV, a fraction f of the cotransporters suddenly
switches to conformation C3, and a number of protons consequently attach
to the cotransporter external site. This will produce a sudden increase in the
trap pH, which is referred to as the step:
step ¼ 2  Ntrap  f
A  Vtrap  b; (3)
SGLT1 Turnover Rate 55where A is the Avogadro number, Vtrap is the volume of the trap, Ntrap is the
number of cotransporters lining the trap, and b is the buffering power of the
external solution given in M/pH unit.
When aMG is added to the external solution, it will equilibrate with the
trap within 20 s (16), and upon applying a voltage step from þ50 to
150 mV, the step will be followed by a progressive alkalinization that
will occur at the actual TOR of the cotransporter. This alkalinization rate
is called the slope and is given by
slope ¼ 2  Ntrap  TOR
A  Vtrap  b : (4)
Clearly, if the step and the slope are obtained from the same experiment
(same Vtrap and same Ntrap), the slope/step ratio yields TOR/f. The TOR can
be calculated if f is estimated from the charge displacement (Q-V curve)
between þ50 and 150 mV. If the cotransport current caused by adding
aMG is measured simultaneously, the number of cotransporters/oocyte
can be obtained using Eq. 1.
Statistics
Data are presented as the average5 SE, where n is the number of oocytes
used (one experiment/oocyte and not more than four oocytes from the same
donor frog), and are compared using Student’s t-test. In the figures, error
bars are not shown when smaller than symbols.RESULTS
Although it is technically possible to measure the cotrans-
porter TOR using Naþ-selective electrodes, we chose to
use pH electrodes in Naþ-free solutions because this
allowed improved accuracy of the TOR determination.
This advantage comes from the possibility of using a low
buffering power in the external solution, which greatlyFIGURE 3 Experimental current and pH signals (VH) measured in 0 mM Na
dashed line in each current recording. Vertical dashed lines on the VH pulses
and 150 mV. (A) Superposed results corresponding to 0 (gray), 5 (black), o
200 mM Pz for the same oocyte. (C) Control experiment done on a noninjectedincreases the amplitude of the signal read by the ISE for
any given change in transmembrane proton transport. With
Naþ-selective electrodes, the only way to improve our
detection limit would be to reduce the background Naþ
concentration, which would also decrease the amplitude of
the transmembrane Naþ transport. For each oocyte studied,
the cotransport current was measured in the presence of Naþ
and 5 mM aMG and at pH 5.5 (Naþ-free solution) with
5 and 35 mM aMG. The TOR in the presence of Naþ was
calculated from the TOR in the presence of Hþ using the
ratio between the two cotransport rates.
Fig. 3 shows a typical pulse protocol with simultaneous
current and VH measurements for an hSGLT1-expressing
oocyte in the presence of Naþ-free solutions (pH 5.5) con-
taining 0, 5, and 35 mM aMG (Fig. 3 A) or 0.2 mM Pz
(Fig. 3 B), as well as measurements for a noninjected oocyte
(Fig. 3 C). When hSGLT1 is active, the step amplitude is on
the order of 0.4–1 mV, which is comparable to the noise
amplitude on a VH trace low-pass-filtered at 200 Hz. Such
a small change in the voltage of a pH-selective electrode
upon changing Vm from þ50 to 150 mV could represent
a true change in the local pH and/or a change in the electri-
cal potential of the trap. The most serious possibility for
a change in the trap voltage would be that the current going
through the membrane area covered by the ISE would
generate a voltage drop as it passes through the loose seal
created between the ISE and the oocyte membrane. This
hypothesis can be ruled out, because in experiments
employing 14 oocytes, the step amplitude did not change
as a function of the external aMG concentration used (theþ solution, pH 5.5. The zero current level is represented by the horizontal
indicate the intervals within which the linear fits were done at þ50 mV
r 35 (gray) mM aMG. (B) Current and VH recordings in the presence of
oocyte in 0 mM aMG.
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0.06 mV in the presence of 0, 5, and 35 mM aMG, respec-
tively; see Fig. 4). In contrast, the observed current
step when the membrane potential was rapidly changed
from þ50 to 150 mVaveraged 8575 52 nA, 12205
86 nA, and 1640 5 110 nA in the presence of 0, 5, and
35 mM aMG, respectively. In other words, the step ampli-
tude varied by less than 4%, whereas the current amplitude
varied by up to twofold. The second observation that
supports the hypothesis that the voltage-dependent reorien-
tation of the proton binding sites is responsible for the step is
that more than half of the step amplitude disappeared in the
presence of Pz. During the experiment shown in Fig. 3, A
and B, which was repeated for 14 oocytes expressing
SGLT1, we measured the step in the presence of a weakly
buffered solution at pH 5.5. The step averaged 0.52 5
0.06 mV in 0 aMG solution but was only 0.21 5
0.03 mV after the addition of 0.2 mM Pz (14 paired
measurements). The fact that a statistically significant step
remains in the presence of Pz indicates that a large negative
voltage step can trigger some nonspecific proton binding to
the lipids or to the proteins embedded in the plasma
membrane. This is confirmed by the observation that nonin-
jected oocytes generate an average step of 0.13 5
0.03 mV (n ¼ 4), not statistically different from the step
observed in the presence of Pz (p ¼ 0.20 in an unpaired
t-test). To further characterize the step, we verified that
the signal was reversible by estimating its value from the
OFF pulse transition. Upon returning to50 mV, a Pz-sensi-
tive step averaging 0.15 5 0.05 mV could be detected
when 0, 5, or 35 mM aMG was present, indicating that
half of all Hþ bound to the cotransporters are released
upon this depolarization.
Another interesting attribute of the measurements was the
presence of a steady-state alkalinization of the trap whenFIGURE 4 Average (5SE) of the rapid pH change (the step) measured
as the membrane potential is stepped from þ50 to 150 mV. The measure-
ments performed in the presence of 0, 5, and 35 mM aMG and 0.2 mM Pz
are from the same 14 oocytes (paired measurements). Control experiments
in 0 mM aMG were performed on noninjected oocytes (n ¼ 4) and their
average is not significantly different from the average step measured in
0.2 mM Pz (p ¼ 0.20, unpaired Student’s t-test).
Biophysical Journal 100(1) 52–59the membrane potential was held at 150 mV (Fig. 3 A).
The results of this analysis are presented in Fig. 5 and
demonstrate that the slope is tightly related to the Hþ/
glucose cotransport activity. Using 14 oocytes, the averageFIGURE 5 Mean values (5SE) of the slope of the VH signal and the cor-
responding oocyte cotransport current at 150 mV. Measurements done in
0, 5, and 35 mM aMG and 0.2 mM Pz were paired (n ¼ 14). Noninjected
oocytes (n ¼ 4) were used as a control. (A) Slope of the linear fit of the VH
signal indicating a steady-state ionic uptake by the membrane patch under
the trap. (B) Current recorded simultaneously with slope. (C) Linear corre-
lation between the Pz-sensitive slope and the Pz-sensitive current. Pz-sensi-
tive signals are calculated by subtracting the signal in 0.2 mM Pz from the
signal obtained in the presence of either 0, 5, or 35 mM aMG.
SGLT1 Turnover Rate 57slope in the presence of Pz was 0.33 5 0.06 mV s1,
and it increased progressively to 1.14 5 0.18 mV s1,
2.30 5 0.27 mV s1, and 4.65 5 0.49 mV s1 when
it was measured in the presence of 0, 5, and 35 mM
aMG, respectively (Fig. 5 A). It is interesting to note that
noninjected oocytes did not generate any significant pH
slope, averaging þ0.03 5 0.07 mV s1 (n ¼ 4) when
they were maintained at 150 mV. In Fig. 5 B, the currents
recorded at150 mVare shown for noninjected oocytes and
for hSGLT1-expressing oocytes in the presence of Pz or 0, 5,
or 35 mM aMG. Finally, Fig. 5 C shows that a linear
correlation exists between the Pz-sensitive slope and the
Pz-sensitive current measured at 150 mV. This confirms
the presence of proton-glucose cotransport in the presence
of glucose and the presence of a leak current in the absence
of glucose, which, as we have recently shown (25), is largely
mediated by protons at low external pH levels. At pH 7.5,
we have also shown that several monovalent cations,
including cations that do not interact with the cotransporter
cation-binding sites, can mediate as much leak current as
Naþ does. This suggests that the leak pathway is distinct
from the Naþ-selective cotransport pathway and present
for both Naþ-bound and Naþ-free conformations of the
cotransporter.
Based on the results presented above, we can proceed to
the calculation of TOR. Since there is a Pz-sensitive proton
flux through SGLT1 in the absence of substrate (see the
Pz-sensitive slope in the absence of aMG in Fig. 5 A), the
cotransporter TOR was estimated using the increase in slope
due to the addition of aMG. The TOR was then obtained
at 150 mV by dividing the aMG-sensitive slope by the
Pz-sensitive step and multiplying the result by the correcting
factor 0.65, which represents the fraction, f, of the cotrans-
porters that experienced a conformational change after the
voltage step from þ50 mV to 150 mV (see Fig. 2 A).
This was done for each of the 14 oocytes exposed
to 35 mM aMG, and the average TOR was found to be
8.00 5 1.3 s1 (see Table 1, where the average step and
slope are also given). Applying Eq. 1, we can use the
TOR and the current caused by the addition of 35 mM
aMG to estimate the number of carriers (N) in the plasma
membrane of each oocyte, assuming that two protons per
transport cycle are translocated. This calculation yieldedTABLE 1 Calculated TOR values associated with different extracel
0 mM Na pH 5.5
5 aMG
Step (mV) Slope (mV s1) I (mA) TOR (s1) Step(mV)
0.315 0.03 1.185 0.12 0.3250.04 2.715 0.38 0.345 0.05
TOR5aMG and TOR35aMG at pH 5.5 are obtained directly from the slope/step ratio
of cotransporters moving in the electrical field of the membrane during a voltage
values are shown (n ¼ 14). The steps used for the calculation were obtained by s
5 or 35 mM aMG. The slopes were obtained by subtracting the slope in 0 mM aM
or 35 mM aMG. Equation 1 was used to calculate TOR5aMG when 90 mM Naan average of 3.6 5 0.7  1011 transporters/oocyte. Using
the same analysis, the TOR corresponding to the addition
of 5 mM aMG at pH 5.5 could also be calculated and aver-
aged at 2.715 0.38 s1. Using the current measured in the
presence of 5 mM aMG, the number of transporters in each
oocyte was calculated and found to be very close to the
number obtained using the measurements with 35 mM
aMG. According to Eq. 1, if we assume that the number
of cotransporters in a given oocyte is constant as a function
of different experimental conditions, the TOR can be
evaluated in each case, as it is simply proportional to the
measured cotransport current. Using this strategy, we
obtained a TOR of 13.3 5 2.4 s1 when 90 mM Naþ and
5 mM aMG (pH 7.5) were present. The results are summa-
rized in Table 1.DISCUSSION
Several estimates of SGLT1 TOR have been made over the
last decades. The method of calculation using the ratio
ICotr=Qmax obtained by electrophysiology has been used
frequently in the cotransporter literature (4,14,26). In prin-
ciple, the Boltzmann equation (Eq. 2) represents a charge
movement across the membrane electrical field as a protein
is oscillating between two conformational states related by
voltage-dependent rate constants. In our case (Fig. 2 B),
there are at least three conformational states in the absence
of substrate, but the Boltzmann equation can still be used
for a rough description of the charge movement. If z is
the number of elementary charges (e) per transporter that
move across the entire electrical field of the membrane,
Qmax is given by
Qmax ¼ N  z  e: (5)
Considering Eqs. 1 and 5, the ratio ICotr=Qmax yields the
TOR as long as the number of charges cotransported, s, is
equal to the number of mobile charges in the absence of
substrate, z. This has been widely accepted because Naþ/
glucose kinetic modeling has put forward the idea that the
empty carrier possesses a charge of 2 e that is neutralized
when two Naþ ions bind to their sites, yielding a situation
where all subsequent kinetic steps are considered electro-
neutral (13,27). However, estimates of the apparent valencylular conditions
90 mM Na pH 7.5
35 aMG 5 aMG
Slope (mV s1) I (mA) TOR (s1) I (mA) TOR (s1)
3.535 0.33 0.705 0.06 8.005 1.3 1.0850.61 13.352.4
s multiplied by the correction factor, f¼ 0.65, corresponding to the fraction
pulse from þ50 to 150 mV. This was done for each oocyte, and the mean
ubtracting the step measured in the presence of 0.2 mM Pz from the step in
G (pH 5.5) buffer from the slopes measured in the presence of 5 mM aMG
þ (pH 7.5) was in the bath.
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values of ~1 in the presence of ~100 mM Naþ (14) (at pH
5.5 in Naþ-free solution, z ¼ 0.45 in this study). In contrast,
measurements of Qmax and N in freeze-fracture experiments
(15) yield an average of 3.5 charges/transporter. This means
that to calculate the TOR using the ratio ICotr=Qmax requires
several corrections where the estimation of the number of
charges/transporter (z) is crucial. If one uses z¼ 1, a stoichi-
ometry s of 2, and the revised estimate of Qmax presented in
Loo et al. (4), the TOR of hSGLT1 in the presence of Naþ
and a large negative membrane potential would be 14 s1,
which agrees with the value of 13.3 s1 obtained in the study
presented here.
Although it is well established that two Naþ ions bind to
SGLT1 to drive glucose across the membrane, we have
made the assumption that the stoichiometry of Hþ/glucose
cotransport is 2:1. This assumption is indeed supported by
experiments with Hþ activation of glucose transport that
yielded a Hill coefficient of 1.5 at 50 mV (21). Conse-
quently, an error in the estimation of the Naþ/glucose
TOR at pH 7.5 from the TOR evaluated at pH 5.5 could
be introduced if the stoichiometry of Hþ/glucose and Naþ/
glucose cotransport happened to be different. The advantage
of a known ion/glucose stoichiometry if we had used Naþ-
sensitive electrodes is negated by the better signal/noise
ratio for ITT when using Hþ-sensitive electrodes.
In Table 1, an estimate of TOR at pH 5.5 is shown. At
pH 5.5, a TOR of 8.005 1.3 s1 at 35 mM aMG is directly
derived from the slope/step ratio. Fig. 4 shows that the
step used in this estimation is related to the presence of
SGLT1, because its value is reduced to comparable levels
when 0.2 mM Pz is present or when the experiment is
done on noninjected oocytes. The step in 0, 5, or 35 mM
aMG is a measurement that represents the number of
protons that rapidly leave the trap to bind to the newly avail-
able sites on carriers that have just experienced a voltage-
dependent conformational change. It is interesting to note
that the step remains constant in the presence of 0, 5, or
35 mM aMG, whereas the pre-steady-state charge move-
ment becomes impossible to measure in the presence of
increasing concentrations of aMG, as it becomes largely
hidden by an important steady-state cotransport current
(22). Measuring the step amplitude with some accuracy is
a crucial part of the determination of TOR. It is difficult to
establish a limit to the minimal cotransporter density
required to estimate TOR with the ITT approach, but we
can state that the step could be measured for oocytes ex-
pressing only 50% of their maximal activity level. The slope
used in the calculation of TOR is also directly related to the
presence of SGLT1 at the plasma membrane. The linear
relationship between the Pz-sensitive current and the
Pz-sensitive slope at pH 5.5 (Fig. 5 C) clearly shows that
an increase in carrier-mediated current is reflected in an
increase in the alkalinization rate of the trap due to the pro-
tons that are translocated with glucose. The TOR has alsoBiophysical Journal 100(1) 52–59allowed us to estimate, using Eq. 1, that 3.6 5 0.7  1011
transporters are expressed at the plasma membrane of
an oocyte. It is interesting to note that this calculation is
independent of the membrane area covered by the trap.
The numbers of transporters obtained in freeze-fracture elec-
tron microscopy were reported to be 0.07, 0.20, and 0.32 
1011 carriers for three SGLT1-expressing oocytes character-
ized by Qmax values of 4, 11.5, and 16 nC, respectively (15).
In this study, 14 oocytes with an average Qmax of 25.8 5
1.6 nC (ranging from 15 to 32 nC)were used. After correction
for the respective Qmax values, the number of transporters
deduced from freeze-fracture appears to be underevaluated
by fourfold. Note that the freeze-fracture study yields an
average of 3.5 charges/particle, which is also 3.5 times larger
than the z value of 1 obtained from a Boltzmann fit of the
Q-V curve. It is possible that the freeze-fracture approach
does not succeed in detecting all SGLT1 particles or that
the section studied, corresponding to 1 mm2, is not represen-
tative of a complete oocyte area of 0.4 cm2.
Table 1 also shows the calculated TOR of 13.35 2.4 s1
at 150 mV, pH 7.5, when 90 mM Naþ and 5 mM aMG are
present. It should be stressed that no first-order rate constant
in the forward direction (Naþ/glucose uptake direction) can
be slower than the TOR. In a simple case where a protein
can adopt two conformations through a forward and a back-
ward rate constant (kf and kb, respectively), the time constant
t associated with the transition is
t ¼ 1
kf þ kb: (6)
In the more complex kinetic model shown in Fig. 2 B,
four time constants are expected, but the value of the longest
time constant cannot be >1/TOR, i.e., 75 ms (1/13.3 s) in
the case of hSGLT1, since all forward rate constants
obey kfR TOR. Over the past few years, electrophysiolog-
ical and fluorometric experiments with extended voltage
pulse durations (up to 500 ms) have revealed the presence
of slow time constants of 80, 110, and even 139 ms associ-
ated with the movements of hSGLT1 at hyperpolarizing
potentials in the absence of substrate (4,27). In view of
the speed at which the cotransporter is capable of mediating
a full cycle, it is doubtful that these slow time constants
can be associated with any of the steps required to mediate
the cotransport process. Our estimation of the TOR using
ITT provides a boundary useful for setting a lower time-
scale for conformational changes directly related to a
cotransport mechanism. The presence of these slow charge
movements or slow fluorescence relaxations may be real,
but they may be related to processes that occur in parallel
with the cotransport mechanism as, for example, a slowly
stabilizing leak current or a local molecular rearrangement
in the immediate vicinity of an attached fluorophore. The
important constraint set by the determination of TOR
must be respected in any kinetic model that aims to describe
the cotransport behavior of hSGLT1.
SGLT1 Turnover Rate 59CONCLUSION
This study shows that ITT can be used to obtain a reliable
and independent estimate of a cotransporter TOR. The
results indicate that the number of hSGLT1 cotransporters
expressed in an oocyte is fourfold larger than previously
estimated using freeze-fracture experiments. In the presence
of Naþ and of a saturating substrate concentration, the
maximal TOR of hSGLT1 is 13.3 5 2.4 s1. This number
has significant consequences in the analysis of electrogenic
and fluorescence kinetics of cotransporters.
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